I

Innocan Pharma Corp
OTC:INNPF

Watchlist Manager
Innocan Pharma Corp
OTC:INNPF
Watchlist
Price: 5.55 USD Market Closed
Market Cap: $1.6B

Relative Value

The Relative Value of one INNPF stock under the Base Case scenario is 8.69 USD. Compared to the current market price of 5.55 USD, Innocan Pharma Corp is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INNPF Relative Value
Base Case
8.69 USD
Undervaluation 36%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Multiples Across Competitors

INNPF Competitors Multiples
Innocan Pharma Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Innocan Pharma Corp
OTC:INNPF
31.5m USD 0.8 -7.1 -10.2 -9.9
IN
Aaswa Trading and Exports Ltd
BSE:512038
24.5T INR 26 144.9 53 052.1 36 622.9 42 959.8
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0 0 0
US
GE Vernova LLC
NYSE:GEV
177.2B USD 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
IN
GTV Engineering Ltd
BSE:539479
4.5T INR 5 210.6 38 358.9 27 648.1 29 121.7
US
CoreWeave Inc
NASDAQ:CRWV
46.3B USD 0 0 0 0
CH
Galderma Group AG
SIX:GALD
35.8B CHF 0 0 0 0
US
Reddit Inc
NYSE:RDDT
41.6B USD 21.8 118.8 140.7 149.3
US
Coupang Inc
F:788
31.6B EUR 1.1 93.6 29.4 48.4
US
Symbotic Inc
NASDAQ:SYM
37B USD 16.5 -2 187.6 -1 089.1 -494
P/S Multiple
Revenue Growth P/S to Growth
IL
I
Innocan Pharma Corp
OTC:INNPF
Average P/S: 4 535.3
0.8
N/A N/A
IN
A
Aaswa Trading and Exports Ltd
BSE:512038
26 144.9
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
12%
N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
5 210.6
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
18%
N/A
US
R
Reddit Inc
NYSE:RDDT
21.8
45%
0.5
US
Coupang Inc
F:788
1.1
15%
0.1
US
Symbotic Inc
NASDAQ:SYM
16.5
24%
0.7
P/E Multiple
Earnings Growth PEG
IL
I
Innocan Pharma Corp
OTC:INNPF
Average P/E: 19 128.8
Negative Multiple: -7.1
N/A N/A
IN
A
Aaswa Trading and Exports Ltd
BSE:512038
53 052.1
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
53%
N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
38 358.9
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
86%
N/A
US
R
Reddit Inc
NYSE:RDDT
118.8
N/A N/A
US
Coupang Inc
F:788
93.6
114%
0.8
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 187.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
I
Innocan Pharma Corp
OTC:INNPF
Average EV/EBITDA: 13 571.7
Negative Multiple: -10.2
N/A N/A
IN
A
Aaswa Trading and Exports Ltd
BSE:512038
36 622.9
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
58%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
27 648.1
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
R
Reddit Inc
NYSE:RDDT
140.7
N/A N/A
US
Coupang Inc
F:788
29.4
56%
0.5
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -1 089.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IL
I
Innocan Pharma Corp
OTC:INNPF
Average EV/EBIT: 15 163.3
Negative Multiple: -9.9
N/A N/A
IN
A
Aaswa Trading and Exports Ltd
BSE:512038
42 959.8
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
99%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
29 121.7
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
R
Reddit Inc
NYSE:RDDT
149.3
N/A N/A
US
Coupang Inc
F:788
48.4
74%
0.7
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -494 N/A N/A